{
  "data": {
    "indicator": {
      "slug": "cumulative-biopharmaceutical-r-d-expenditure",
      "name": "Cumulative biopharmaceutical R&D expenditure",
      "definition": "Cumulative capital expenditure invested in biopharmaceutical research and development across member companies over a designated period.",
      "unit": "USD",
      "scale": "trillion",
      "default_unit": "USD",
      "default_scale": "trillion"
    },
    "scale": "trillion",
    "unit": "USD",
    "region": {
      "code": "US",
      "name": "United States",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2000-01-01",
        "period_label": "2000–2025",
        "value": 1,
        "scale": "trillion",
        "unit": "USD",
        "value_type": "actual",
        "statistic_id": "stat_C9H3H7G4QK2418S8SH3H1NE64T",
        "url": "https://statorigin.org/stat/stat_C9H3H7G4QK2418S8SH3H1NE64T",
        "source_org": "PhRMA",
        "source": {
          "org": "PhRMA",
          "org_short_name": "PhRMA",
          "document_title": "Research & Development",
          "document_url": "https://phrma.org/policy-issues/research-development",
          "locator": "Committed to Research",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "US"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}